(PINC) Premier - Ratings and Ratios

Premier Inc. (NASDAQ:PINC) is a leading healthcare improvement company that operates through two primary segments: Supply Chain Services and Performance Services. The Supply Chain Services segment provides its members with access to a comprehensive range of products and services, including medical and surgical supplies, pharmaceuticals, laboratory equipment, capital equipment, IT solutions, facilities and construction materials, and food and nutritional products. Additionally, this segment offers purchased services such as clinical engineering and workforce solutions. It also provides specialized programs like ASCENDrive, which offers group purchasing benefits, SURPASS Performance Group for coordinated purchasing decisions, and supply chain co-management services. These initiatives aim to enhance efficiency and cost-effectiveness for healthcare providers.

The Performance Services segment delivers a technology and services platform designed to optimize clinical, financial, and operational performance. Under the PINC AI brand, the company offers advanced analytics and AI-driven solutions to improve clinical outcomes, reduce costs, and support value-based care models. Through the Contigo Health brand, Premier provides third-party administrator services and manages health benefit programs. Additionally, the Remitra brand offers digital invoicing and payables services, streamlining financial operations for healthcare suppliers. Premier Inc. was founded in 2013 and is headquartered in Charlotte, North Carolina.

Ticker Symbol: PINC
Exchange: NASDAQ
Type: Common Stock
Country Origin: United States
GICS Sub Industry: Health Care Services

Average Volume 20d: 1,145,001
Last Price: 20.35
SMA 20: 19.60
SMA 50: 18.90
SMA 200: 19.96
ATR: 0.49

Market Cap: $1,931.46M USD
P/E: 50.24
P/E Forward: 16.23
P/B: 1.07
P/S: 1.50
RoE: -0.28

3-Month Forecast:
Based on the technical and fundamental data, Premier Inc. (PINC) is expected to experience moderate volatility with potential upward momentum. The crossing of the SMA20 above the SMA50 suggests short-term bullish signals, while the proximity to the SMA200 indicates support at current levels. The low ATR of 0.49 points to reduced price fluctuations. On the fundamental side, the high P/E ratio of 50.24, paired with a lower forward P/E of 16.23, suggests market expectations of improved earnings. However, the negative RoE of -0.28 raises concerns about profitability. Overall, the stock may see sideways movement with occasional rallies, driven by its strong market position and growth prospects in healthcare technology and services.